These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19133777)

  • 21. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
    Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
    Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2,5-Diphenylfuran-based pure antiestrogens with selectivity for the estrogen receptor alpha.
    Zimmermann J; Liebl R; von Angerer E
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):57-66. PubMed ID: 15862950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
    Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
    Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
    Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
    J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of stilbene-based pure estrogen antagonists.
    Walter G; Liebl R; von Angerer E
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4659-63. PubMed ID: 15324884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells.
    Journé F; Dumon JC; Kheddoumi N; Fox J; Laïos I; Leclercq G; Body JJ
    Bone; 2004 Aug; 35(2):479-88. PubMed ID: 15268900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells.
    Paredes J; Stove C; Stove V; Milanezi F; Van Marck V; Derycke L; Mareel M; Bracke M; Schmitt F
    Cancer Res; 2004 Nov; 64(22):8309-17. PubMed ID: 15548699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulvestrant (Faslodex): current status in the therapy of breast cancer.
    Bundred N; Howell A
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):151-60. PubMed ID: 12113237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
    Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
    Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of estrogen on DNA synthesis in human periodontal ligament and breast cancer cells.
    Jönsson D; Wahlin A; Idvall I; Johnsson I; Bratthall G; Nilsson BO
    J Periodontal Res; 2005 Oct; 40(5):401-6. PubMed ID: 16105093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.
    Zhao L; Jin C; Mao Z; Gopinathan MB; Rehder K; Brinton RD
    J Med Chem; 2007 Sep; 50(18):4471-81. PubMed ID: 17696335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.
    Yao Y; Zhou Q
    Breast Cancer Res Treat; 2010 May; 121(1):233-40. PubMed ID: 19760501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.
    Sharma A; Toy W; Guillen VS; Sharma N; Min J; Carlson KE; Mayne CG; Lin S; Sabio M; Greene G; Katzenellenbogen BS; Chandarlapaty S; Katzenellenbogen JA
    ACS Chem Biol; 2018 Dec; 13(12):3374-3384. PubMed ID: 30404440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.
    Min J; Guillen VS; Sharma A; Zhao Y; Ziegler Y; Gong P; Mayne CG; Srinivasan S; Kim SH; Carlson KE; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2017 Jul; 60(14):6321-6336. PubMed ID: 28657320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of Novel Breast Cancer Therapeutic Drug Candidates Based upon the Hydrophobic Feedback Approach of Antiestrogens.
    Ohta K; Kaise A; Taguchi F; Aoto S; Ogawa T; Endo Y
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31683895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and biological evaluation of 7 alpha-perfluoroalkylestradiol derivatives.
    Blazejewski JC; Wilmshurst MP; Popkin MD; Wakselman C; Laurent G; Nonclercq D; Cleeren A; Ma Y; Seo HS; Leclercq G
    Bioorg Med Chem; 2003 Feb; 11(3):335-45. PubMed ID: 12517429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.